Pharmexcil embarks on brand-building
The newly-formed Pharmaceutical Export Promotion Council (Pharmexcil), under the ministry of commerce, has proposed to undertake a brand building exercise. With growth in the pharma industry in terms of exports touching Rs 14,000 crore in the year 2004, the Pharmexcil is negotiating with five top international consulting agencies to undertake the brand-building exercise.

Torrent zooms in on Pfizer’s German unit
Ahmedabad-based Torrent Pharma has firmed up plans to acquire Germany-based Heumann Pharma GmbH & Co Generica KG, through its wholly-owned subsidiary, Torrent Pharma GmbH. The acquisition excludes manufacturing facilities which will be retained by Heumann PCS GmbH, a wholly-owned subsidiary of Pfizer group.

Biocon-Clinigene, Scirex to collaborate on global clinical trials
Biocon Ltd has announced that Clinigene International, a wholly owned subsidiary of the company and Scirex Corporation, a wholly owned subsidiary of the Omnicom Group has signed a Letter of Intent (LOI) to collaborate on global clinical trials.